a developer of therapeutics and drug delivery technologies to address chronic inflammatory diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, APLS has been loosely correlated with RCUS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then RCUS could also see price increases.
Ticker / NAME | Correlation To APLS | 1D Price Change % | ||
---|---|---|---|---|
APLS | 100% | -0.26% | ||
RCUS - APLS | 40% Loosely correlated | -3.21% | ||
ABCZF - APLS | 36% Loosely correlated | N/A | ||
ZYME - APLS | 33% Loosely correlated | -1.79% | ||
AVIR - APLS | 33% Loosely correlated | -5.71% | ||
INZY - APLS | 33% Poorly correlated | -5.60% | ||
More |
Ticker / NAME | Correlation To APLS | 1D Price Change % |
---|---|---|
APLS | 100% | -0.26% |
therapeutics theme (57 stocks) | 40% Loosely correlated | +20.54% |
diseases theme (42 stocks) | 39% Loosely correlated | +1.03% |
drugs theme (265 stocks) | 37% Loosely correlated | +5.37% |
medical devices theme (64 stocks) | 23% Poorly correlated | +0.44% |